Abstract

Objective: Citation and download data pertaining to the 2009 AACN consensus statement on validity assessment indicated that the topic maintained high interest in subsequent years, during which key terminology evolved and relevant empirical research proliferated. With a general goal of providing current guidance to the clinical neuropsychology community regarding this important topic, the specific update goals were to: identify current key definitions of terms relevant to validity assessment; learn what experts believe should be reaffirmed from the original consensus paper, as well as new consensus points; and incorporate the latest recommendations regarding the use of validity testing, as well as current application of the term ‘malingering.’ Methods: In the spring of 2019, four of the original 2009 work group chairs and additional experts for each work group were impaneled. A total of 20 individuals shared ideas and writing drafts until reaching consensus on January 21, 2021. Results: Consensus was reached regarding affirmation of prior salient points that continue to garner clinical and scientific support, as well as creation of new points. The resulting consensus statement addresses definitions and differential diagnosis, performance and symptom validity assessment, and research design and statistical issues. Conclusions/Importance: In order to provide bases for diagnoses and interpretations, the current consensus is that all clinical and forensic evaluations must proactively address the degree to which results of neuropsychological and psychological testing are valid. There is a strong and continually-growing evidence-based literature on which practitioners can confidently base their judgments regarding the selection and interpretation of validity measures.

摘要

目标：与 2009 年 AACN 有效性评估共识声明相关的引用和下载数据表明，该主题在随后的几年中保持着很高的兴趣，在此期间关键术语不断发展，相关实证研究激增。总体目标是为临床神经心理学界提供有关这一重要主题的当前指导，具体更新目标是： 确定与有效性评估相关的术语的当前关键定义；从原始共识文件中了解专家认为应该重申的内容，以及新的共识点；并纳入有关有效性测试使用的最新建议，以及“伪装”一词的当前应用。方法：2019 年春季，原 2009 年工作组的四位主席和每个工作组的额外专家被任命。共有 20 人分享想法和撰写草稿，直至 2021 年 1 月 21 日达成共识。结果：就确认继续获得临床和科学支持的先前突出点以及创建新点达成了共识。由此产生的共识声明解决了定义和鉴别诊断、性能和症状有效性评估以及研究设计和统计问题。结论/重要性：为了提供诊断和解释的基础，目前的共识是所有临床和法医评估都必须主动解决神经心理和心理测试结果的有效程度。有大量且不断增长的循证文献，从业者可以根据这些文献自信地对有效性度量的选择和解释做出判断。